Gestational Trophoblastic Tumor Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell TumorInterventions: Biological: aldesleukin; Biological: recombinant interferon alfa; Biological: sargramostimSponsors: National Cancer Institute (NCI); Cancer Treatment Centers of AmericaCompleted - verified April 2003 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Conditions: Hydatidiform Mole; Low Risk Metastatic Gestational Trophoblastic Tumor; Nonmetastatic Gestational Trophoblastic Tumor; Uterine ChoriocarcinomaInterventions: Biological: dactinomycin; Drug: methotrexateSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompleted - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell TumorInterventions: Biological: aldesleukin; Biological: recombinant interferon alfa; Biological: sargramostimSponsors: National Cancer Institute (NCI); Cancer Treatment Centers of AmericaCompleted - verified April 2003 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Conditions: Hydatidiform Mole; Low Risk Metastatic Gestational Trophoblastic Tumor; Nonmetastatic Gestational Trophoblastic Tumor; Uterine ChoriocarcinomaInterventions: Biological: dactinomycin; Drug: methotrexateSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompleted - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell TumorInterventions: Biological: aldesleukin; Biological: recombinant interferon alfa; Biological: sargramostimSponsors: National Cancer Institute (NCI); Cancer Treatment Centers of AmericaCompleted - verified April 2003 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Conditions: Hydatidiform Mole; Low Risk Metastatic Gestational Trophoblastic Tumor; Nonmetastatic Gestational Trophoblastic Tumor; Uterine ChoriocarcinomaInterventions: Biological: dactinomycin; Drug: methotrexateSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompleted - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 1999 Category: Research Source Type: clinical trials